Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Avid Bioservices, Peregrine Pharmaceuticals' contract manufacturing subsidiary, has started expansion of its biomanufacturing capacity, which will take place within an existing 40,000ft² warehouse located adjacent to the company's current campus.
Subscribe to our email newsletter
The new production facility will more than double the company’s existing manufacturing capacity in a facility design.
The company offers clinical and commercial manufacturing services under cGMP for the biotechnology and biopharmaceutical industries.
The new cGMP facility will employ a flexible modular clean room design and the latest in single-use technologies that provide expanded capacity to meet the growing needs of the company’s existing and future clients.
It will accommodate multiple single use bioreactors of up to 2,000 liters, downstream processing suites, and dedicated support utilities that will allow for the production of a variety of biological products.
Avid president Steven King said: "This new production suite will be a key component of our strategic growth as it allows us to meet the increasing demand for our clinical and commercial manufacturing.
"As one of the early adopters of single-use technology, this expansion allows us to build upon our expertise in what is now a common mainstream practice for biologics production and is in line with our commitment to providing our clients with the highest quality service offerings to meet every phase of development and production."
According to the company, the new facility is expected to be ready for cGMP production in mid-2015.